Displaying items by tag: division of hematology and oncology

UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.
New UAB research demonstrates social factors that determine survival of younger patients with AML and present opportunities to improve outcomes.
Internationally renowned husband and wife cancer researchers join UAB and showcase its  recruitment muscle

Weakened immune systems due to diseases like cancer cause increased risk of severe complications from the flu virus — experts advise vaccine shot, not mist.

PNP Therapeutics, UAB and Southern Research Institute work abolishes otherwise unmanageable human cancers in preclinical rodent studies.

Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting colorectal cancer patients’ response.
UAB cancer expert provides the deeper understanding on summer skin protection from UV rays, offers helpful tips.

“Complementary and Alternative Therapies: What You (And Your Doctor) Don’t Know Can Hurt You” to be held Jan. 24

New clinic provides high-quality care with infusion therapy to Bessemer and Tuscaloosa-area communities.
Harry P. Erba, M.D., Ph.D., the inaugural holder of the Albert F. LoBuglio Endowed Chair for Translational Cancer Research

New director to help establish UAB as the South’s leading center for treating leukemia, lymphoma, multiple myeloma and related diseases.

UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.

Forero-Torres will be the first holder of a professorship position endowed by the O'Neal-Sokol Breast Cancer Research Foundation of Alabama.

Page 5 of 6